-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Management of AL Amyloidosis in 2020

Program: Education Program
Session: Monoclonal Gammopathies of Determined Significance
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, antibodies, therapy sequence, Adult, Diseases, smoldering myeloma, Non-Biological, Therapies, Combinations, chemotherapy, Plasma Cell Disorders, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant
Sunday, December 6, 2020, 1:55 PM-2:00 PM

Giovanni Palladini, MD, PhD

Università Degli Studi Di Pavia, Pavia, Italy

Disclosures: Palladini: Jannsen Cilag: Honoraria, Other; Celgene: Other: Travel support.

OffLabel Disclosure:

Previous Presentation | Next Presentation >>